Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome.

Authors

April Zhang
Sabine Duchatelet
Nikita Lakdawala
Richard L Tower
Carrie Diamond, George Washington University
Kalyani Marathe, George Washington University
India Hill
Gabriele Richard
Yaser Diab, George Washington University
Anna Yasmine Kirkorian, George Washington University
Flora Watanabe
Dawn H Siegel
Alain Hovnanian

Document Type

Journal Article

Publication Date

1-2-2020

Journal

JAMA Dermatology

DOI

10.1001/jamadermatol.2019.4141

Comments

Epub ahead of print

APA Citation

Zhang, A., Duchatelet, S., Lakdawala, N., Tower, R., Diamond, C., Marathe, K., Hill, I., Richard, G., Diab, Y., Kirkorian, A. Y., Watanabe, F., Siegel, D., & Hovnanian, A. (2020). Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome.. JAMA Dermatology, (). http://dx.doi.org/10.1001/jamadermatol.2019.4141

Peer Reviewed

1